Cargando…

Nanocarriers for Inner Ear Disease Therapy

Hearing loss is a common disease due to sensory loss caused by the diseases in the inner ear. The development of delivery systems for inner ear disease therapy is important to achieve high efficiency and reduce side effects. Currently, traditional drug delivery systems exhibit the potential to be us...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Xiaoxiang, Zheng, Jianwei, He, Yanze, Lin, Kun, Li, Shuang, Zhang, Ya, Song, Peng, Zhou, Yuye, Chen, Xiong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8677824/
https://www.ncbi.nlm.nih.gov/pubmed/34924960
http://dx.doi.org/10.3389/fncel.2021.791573
_version_ 1784616223586123776
author Xu, Xiaoxiang
Zheng, Jianwei
He, Yanze
Lin, Kun
Li, Shuang
Zhang, Ya
Song, Peng
Zhou, Yuye
Chen, Xiong
author_facet Xu, Xiaoxiang
Zheng, Jianwei
He, Yanze
Lin, Kun
Li, Shuang
Zhang, Ya
Song, Peng
Zhou, Yuye
Chen, Xiong
author_sort Xu, Xiaoxiang
collection PubMed
description Hearing loss is a common disease due to sensory loss caused by the diseases in the inner ear. The development of delivery systems for inner ear disease therapy is important to achieve high efficiency and reduce side effects. Currently, traditional drug delivery systems exhibit the potential to be used for inner ear disease therapy, but there are still some drawbacks. As nanotechnology is developing these years, one of the solutions is to develop nanoparticle-based delivery systems for inner ear disease therapy. Various nanoparticles, such as soft material and inorganic-based nanoparticles, have been designed, tested, and showed controlled delivery of drugs, improved targeting property to specific cells, and reduced systemic side effects. In this review, we summarized recent progress in nanocarriers for inner ear disease therapy. This review provides useful information on developing promising nanocarriers for the efficient treatment of inner ear diseases and for further clinical applications for inner ear disease therapy.
format Online
Article
Text
id pubmed-8677824
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-86778242021-12-18 Nanocarriers for Inner Ear Disease Therapy Xu, Xiaoxiang Zheng, Jianwei He, Yanze Lin, Kun Li, Shuang Zhang, Ya Song, Peng Zhou, Yuye Chen, Xiong Front Cell Neurosci Cellular Neuroscience Hearing loss is a common disease due to sensory loss caused by the diseases in the inner ear. The development of delivery systems for inner ear disease therapy is important to achieve high efficiency and reduce side effects. Currently, traditional drug delivery systems exhibit the potential to be used for inner ear disease therapy, but there are still some drawbacks. As nanotechnology is developing these years, one of the solutions is to develop nanoparticle-based delivery systems for inner ear disease therapy. Various nanoparticles, such as soft material and inorganic-based nanoparticles, have been designed, tested, and showed controlled delivery of drugs, improved targeting property to specific cells, and reduced systemic side effects. In this review, we summarized recent progress in nanocarriers for inner ear disease therapy. This review provides useful information on developing promising nanocarriers for the efficient treatment of inner ear diseases and for further clinical applications for inner ear disease therapy. Frontiers Media S.A. 2021-12-03 /pmc/articles/PMC8677824/ /pubmed/34924960 http://dx.doi.org/10.3389/fncel.2021.791573 Text en Copyright © 2021 Xu, Zheng, He, Lin, Li, Zhang, Song, Zhou and Chen. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cellular Neuroscience
Xu, Xiaoxiang
Zheng, Jianwei
He, Yanze
Lin, Kun
Li, Shuang
Zhang, Ya
Song, Peng
Zhou, Yuye
Chen, Xiong
Nanocarriers for Inner Ear Disease Therapy
title Nanocarriers for Inner Ear Disease Therapy
title_full Nanocarriers for Inner Ear Disease Therapy
title_fullStr Nanocarriers for Inner Ear Disease Therapy
title_full_unstemmed Nanocarriers for Inner Ear Disease Therapy
title_short Nanocarriers for Inner Ear Disease Therapy
title_sort nanocarriers for inner ear disease therapy
topic Cellular Neuroscience
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8677824/
https://www.ncbi.nlm.nih.gov/pubmed/34924960
http://dx.doi.org/10.3389/fncel.2021.791573
work_keys_str_mv AT xuxiaoxiang nanocarriersforinnereardiseasetherapy
AT zhengjianwei nanocarriersforinnereardiseasetherapy
AT heyanze nanocarriersforinnereardiseasetherapy
AT linkun nanocarriersforinnereardiseasetherapy
AT lishuang nanocarriersforinnereardiseasetherapy
AT zhangya nanocarriersforinnereardiseasetherapy
AT songpeng nanocarriersforinnereardiseasetherapy
AT zhouyuye nanocarriersforinnereardiseasetherapy
AT chenxiong nanocarriersforinnereardiseasetherapy